Aberrant splicing of the PTPRD gene mimics microdeletions identified at this locus in neuroblastomas

Genes Chromosomes and Cancer

Volumn 47, Issue 3, 2008, Pages 197-202

  Nair, Prakash ^a   DePreter, Katleen ^b   Vandesompele, Jo ^b   Speleman, Frank ^b   Stallings, Raymond L ^a,c,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR D; RECEPTOR; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADRENERGIC SYSTEM; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; EXON; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRECURSOR; PRIMARY TUMOR; PRIORITY JOURNAL; RNA SEQUENCE; RNA SPLICING; RNA STABILITY;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; BIOPSY; CELL LINE, TUMOR; DNA, NEOPLASM; HUMANS; NEUROBLASTOMA; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RNA SPLICING; SEQUENCE DELETION;

EID: 38549166548     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20521     Document Type: Article

References (16)

1. Brodeur GM. 2003. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216.
2. Brodeur GM, Look AT, Shimada H, Hamilton VM, Maris JM, Hann HW, Leclerc JM, Bernstein M, Brisson LC, Brossard J, Lemieux B, Tuchman M, Woods WG. 2001. Biological aspects of neuroblastomas identified by mass screening in Quebec. Med Pediatr Oncol 36:157-159.
3. De Preter K, Vandesompele J, Heimann P, Yigit N, Beckman S, Schramm A, Eggert A, Stallings RL, Benoit Y, Renard M, De Paepe A, Laureys G, Pahlman S, Speleman F. 2006. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol 7:R84.
4. Gonzalez-Quevedo R, Shoffer M, Horng L, Oro AE. 2005. Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4. J Cell Biol 168:453-463.
5. Pulido R, Serra-Pages C, Tang M, Streuli M. 1995. The LAR/PTP δ/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: Multiple human LAR, PTP δ and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1. Proc Natl Acad Sci USA 92:11686-11690.
6. Purdie KJ, Lambert SR, Teh MT, Chaplin T, Molloy G, Raghavan M, Kelsell DP, Leigh IM, Harwood CA, Proby CM, Young BD. 2007. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer 46:661-669.
7. Sato M, Takahashi K, Nagayama K, Arai Y, Ito N, Okada M, Minna JD, Yokota J, Kohno T. 2005. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer 44:405-414.
8. Schleiermacher G, Janoueix-Lerosey I, Combaret V, Derre J, Couturier J, Aurias A, Delattre O. 2003. Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma. Cancer Genet Cytogenet 141:32-42.
9. Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, Nair P, Brothman AR, Stallings RL. 2005. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44:305-319.
10. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP. 1999. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86:364-372.
11. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Farmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
12. Stallings RL, Nair P, Maris JM, Catehpoole D, McDermott M, O'Meara A, Breatnach F. 2006. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res 66:3673-3680.
13. Stark M, Hayward N. 2007. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 67:2632-2642.
14. Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gselinck J, De Paepe A, Speleman F. 1998. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23:141-152.
15. Woodings JA, Sharp SJ, Machesky LM. 2003. MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J 371(Part 2):463-471.
16. Zhao X, Weir BA, LaFamboise T, Lin M, Beroukhim R, Garraway L, Beheshti J, Lee JC, Naoki K, Richards WG, Sugarbaker D, Chen F, Rubin MA, Janne PA, Girard L, Minna J, Christiani D, Li C, Sellers WR, Meyerson M. 2005. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 65:5561-5570.